{"nct_id":"NCT01416571","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2011-08-12","start_date_type":null,"primary_completion_date":"2011-11-29","primary_completion_date_type":"ACTUAL","completion_date":"2012-09-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}